Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Fimecs
company
About
FIMECS is a focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases.
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- ¥260M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 18, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300 proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥260M
Fimecs has raised a total of
¥260M
in funding over 2 rounds. Their latest funding was raised on
Apr 1, 2018 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 1, 2018 | Seed | ¥260M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
